Featured Posts

Chase Bank Limits Cash Withdrawals, Bans International... Before you read this report, remember to sign up to for 100% free stock alerts Chase Bank has moved to limit cash withdrawals while banning business customers from sending...

Read more

Richemont chairman Johann Rupert to take 'grey gap... Billionaire 62-year-old to take 12 months off from Cartier and Montblanc luxury goods groupRichemont's chairman and founder Johann Rupert is to take a year off from September, leaving management of the...

Read more

Cambodia: aftermath of fatal shoe factory collapse... Workers clear rubble following the collapse of a shoe factory in Kampong Speu, Cambodia, on Thursday

Read more

Spate of recent shock departures by 50-something CEOs While the rising financial rewards of running a modern multinational have been well publicised, executive recruiters say the pressures of the job have also been ratcheted upOn approaching his 60th birthday...

Read more

UK Uncut loses legal challenge over Goldman Sachs tax... While judge agreed the deal was 'not a glorious episode in the history of the Revenue', he ruled it was not unlawfulCampaign group UK Uncut Legal Action has lost its high court challenge over the legality...

Read more

Motorola ‘abused patent position’

Category : Business

Motorola “abused its position” when it filed a patent injunction against Apple in Germany, EU officials say.

Read the original post: Motorola ‘abused patent position’

Post to Twitter

Cash is on the line when Facebook comes calling…

Category : Business

Facebook has more than a billion users, and is bidding to reach more by a smartphone takeover – with a twist

Infectious diseases, says the World Health Organisation, “are caused by pathogenic microorganisms, such as bacteria, viruses, parasites or fungi; the diseases can be spread, directly or indirectly, from one person to another.” Quite so. Just like Facebook addiction, which also spreads from person to person and has now reached pandemic proportions, with more than a billion sufferers worldwide.

The Facebook pathogen doesn’t kill people, of course, for the good reason that dead people don’t buy stuff. But it does seem to affect victims’ brains. For example, it reduces normally articulate and sophisticated people to gibbering in the online equivalent of grunts. Likewise, it obliges them to coalesce all the varieties of human relationships into a simply binary pair: “friends” v everyone else. I have some real friends – as opposed to “friends” – on Facebook and every so often one of them posts a comment on something I’ve written. I’ve just looked at one such observation. It’s thoughtful, subtle and nicely written. But beneath it is a button simply labelled “Like”. If I click on it, my friend will doubtless receive a message from Facebook telling him that I “like” his comment. Big deal.

What’s interesting about this is the way a software system has been designed to strip all of the nuances and complexities that characterise human interaction and compress them into a channel with the bandwidth of Morse code. Actually, the bandwidth is even more attenuated than that. At least with Morse, something can be either a dot or a dash, but Facebook lacks even that binary sophistication. It only has a “Like” button, possibly because a “Dislike” one might facilitate a higher level of discourse than that deemed desirable by the system’s architect.

Cultural critic Neil Postman once observed that you can’t use smoke signals for philosophical discussions: the communication channel simply doesn’t have the necessary bandwidth. One wonders what he would have made of Facebook, or of the fact that a sixth of the world’s population is apparently satisfied by such a primitive medium of communication.

Meanwhile, the efforts of Facebook’s owners to “monetise” these poor saps continue unabated. The basic idea is to use their personal data to refine the targeting of ads at them, which means that, as time goes on, the system becomes more and more tiresome to use. This raises the spectre that, one day, the worms might turn and depart.

But – hey! – Facebook management has a plan for that too. It’s revealed in a fascinating patent application just published. Like all patent applications, it consists of three coats of prime technical verbiage, and the devil is in the detail, but the essence of it is that in exchange for a monthly payment Facebook users will be able to get rid of ads and specify exactly what should replace them on their personal profiles. This is subtly different from what other “freemium” services like Spotify currently offer.

You have to admire the chutzpah implicit in this. First, you bombard your hapless users with ads. Then you offer them relief in return for payment. There’s a word for this in English, but m’learned friends don’t approve of it, so I will avoid it. I’ll be surprised if the patent is approved, but the US Patent and Trademark Office has a track record in granting daft patents, as, for example, US Patent 5,443,036 for a method of exercising a cat by getting it to follow a spot generated by a laser pointer, so I might be unduly optimistic.

For fiendish ingenuity, however, Facebook’s latest move into the mobile phone business takes the biscuit. Neatly avoiding the trap of getting into the handset-manufacturing game, the company has instead developed an Android app that really ought to be codenamed Cuckoo because it effectively takes over any handset on which it is installed. It can be downloaded for a subset of recent Android handsets and last week HTC unveiled the first phone that comes with Facebook Home pre-installed. The app conceals the array of apps that normally dominate Android home screens and instead puts Facebook activity squarely in the centre of the phone’s screen. It splashes status updates across the phone’s lock and home screens and makes Facebook’s messenger application ubiquitous with little “Chat Heads” that follow you from app to app, thereby making it easy to keep up with what pass for “conversations” on Facebook.

What Facebook Home means, of course, is that Facebook will be the first – and perhaps the only – thing that new users of smartphones, especially in emerging markets (ie poor countries), see when they fire up their phones. And when they want to search for something, why, they will use Facebook’s search engine rather than that of Google, the company that created the operating system on which Facebook’s app runs. Howzat!

Company profits depend on the ‘welfare payments’ they get from society | Ha-Joon Chang

Category : Business

The free market is a myth. From drug patents to quantitative easing, businesses make money because of state help

Earlier this week, India’s supreme court ruled that the country will not grant a patent to Novartis, the Swiss pharmaceutical company, for the cancer drug, Glivec. Being a new version of an existing drug, the ruling said, it does not deliver enough innovation to warrant a patent. Novartis condemned the ruling as “a setback for patients that will hinder medical progress for diseases without effective treatment options”.

This statement is rich coming from a company from Switzerland – a country that infamously had no patent law until 1888, half a century after its introduction in most rich capitalist countries.

Even after 1888, Switzerland refused to award pharmaceutical and other chemical patents for two decades, the new patent law having stipulated that patents are granted only to “inventions that can be represented by mechanical models”. The country introduced chemical patents only in 1907 under intense pressure from Germany, whose technologies its pharmaceutical companies were liberally “borrowing”. Ciba-Geigy and Sandoz, whose merger in 1996 created Novartis, were among those companies.

What is more, until 1978, Switzerland granted patents only for chemical process (that is, how you make a chemical) and not for chemical substance (that is, the chemical itself), on the reasonable ground that the substance had always existed in nature and the “inventor” has only found a way of isolating it. This was actually a rather widely accepted view at the time. Germany and France had only just introduced chemical substance patents in the late 1960s. Canada and Spain refused to grant patents to pharmaceutical substances until 1992.

Despite all this history, the pharmaceutical industry is extremely aggressive with substance patents, as in the case of Glivec, because it knows that its

Post to Twitter

VIDEO: India rejects Novartis patent

Category : Business

In a landmark ruling India has rejected a patent bid by Novartis that activists say will protect access to cheap generic drugs and save lives in developing nations.

The rest is here: VIDEO: India rejects Novartis patent

Post to Twitter

Apple denied iPad Mini US trademark

Category : Business

Apple is denied a trademark for the popular iPad Mini by the US Patent and Trademark Office on the grounds it is “merely descriptive”.

Read the rest here: Apple denied iPad Mini US trademark

Post to Twitter

India rejects Novartis patent plea

Category : Business, World News

India’s Supreme Court rejects a plea by Swiss company Novartis to patent an updated version of its cancer drug, Glivec.

Link: India rejects Novartis patent plea

Post to Twitter

Viratech Corp. (VIRA: OTC Pink Current) | Viratch Announces Agreement For Exclusive Marketing License For Method To Stabalize Omega Health Products

Category : World News


CALIFORNIA/March 12, 2013 / Newswire/ — Viratech Corp. (OTC: VIRA), the first
open source biotech research social network platform, announced today
the signing of an agreement for an
exclusive license from Health Care Intellectual Properties, LLC to Viratech,
United States Provisional Patent Application 61672759, titled “Method of
Stabilizing Omega Fatty Acids.”

provisional patent describes an oral formulation and a method of attaining the
proper balance of stabilized antioxidants. It includes a way to naturally
stabilize an omega formula, which prevents oxidation. This is important for
their effectiveness as anti-oxidants. “Otherwise,” as Dr. Buckman, Viratech’s
CEO, states, “they can easily become oxidants instead of anti-oxidants. Fish
oils, flax, rice bran and other nutraceuticals with essential fatty acids can
readily become oxidized, which is the exact opposite of what we want in our
bodies. If they smell rancid, that means they are oxidized and are harmful, the
same with nuts that have gone stale. This formula is designed to prevent this
from happening to make the best use of the ingredients.” Health Care
Intellectual Properties is the holding company for Dr. Buckman’s patents
licensed to Viratech on an exclusive basis. This will also allow Viratech to
sub-license this technology to other companies.

risk for sudden cardiac death may be reduced dramatically in individuals with
the best Omega-3 index radio. The ideal omega-6 to omega-3 ratio is 3 to 1.
Unfortunately, it can be as high as 21 to 1 in Americans’ diets, which is a very
unhealthy ratio.

Post to Twitter

Viratech Corp. (VIRA: OTC Link) | Viratech Announces Agreement For Exclusive Marketing License For Method To Treat Breast Disease

Category : Stocks


STOCKTON, CALIFORNIA/March 8 , 2013 / Newswire/ — Viratech Corp. (OTC: VIRA), the first open source biotech research social network platform, announced today the signing of an agreement for an exclusive license from Health Care Intellectual Properties, LLC to Viratech, Corp, for United States Provisional Patent Application 61696297, titled “Method of Treating Breast Disease.”

Breast cancer is a common cancer in women. Early diagnosis and treatments are vital for better outcomes. This formula consists of an anti-disease, anti-cancer formula with a technology designed for the treatment breast disease, including cancer.

Post to Twitter

Samsung loses Apple case in UK

Category : World News

South Korean phone-maker Samsung loses another patent fight against rival Apple, in the UK High Court.

View post: Samsung loses Apple case in UK

Post to Twitter

Viratech Corp. (VIRA: OTC Link) | Viratech Announces agreement For Marketing License of Device Used For Breast Health

Category : Stocks


STOCKTON, CALIFORNIA/March 6, /Date, 20132 / Newswire/ — Viratech, Corp. (OTC: VIRA), the first open source biotech research social network platform, announced today the signing of an agreement for a license issued to Viratech from Health Care Intellectual Properties, LLC.

The patent is called a “Method of Making and Using a Device to Warm the Breast Prior to, and to Assist with, the Elicitation of Fluid, As Part of a Nipple Aspirate Fluid Test Kit or Part of a Breast Ductal Therapy Infusion Kit or Breast Topical Therapy Protocol,” provisional patent application number 61518691.

Each year approximately 200,000 new patients with breast cancer are diagnosed in North America, and 50,000 of those will die of the disease. Despite billions of dollars poured into research, public awareness, and improved treatment, the statistics have shown only modest improvement over the past twenty years. The slight increase in survival is attributable somewhat to earlier diagnosis but mostly to improved treatment.

Post to Twitter